Aid offered for development of homegrown COVID-19 vaccine
The Ministry of Health (MoH) on February 27 received 20 billion VND (866,620 USD) from conglomerate Vingroup for the clinical trials of homegrown COVID-19 vaccine COVIVAC.
Hanoi (VNA) - The Ministry of Health (MoH) on February 27 received 20 billion VND (866,620 USD) from conglomerate Vingroup for the clinical trials of homegrown COVID-19 vaccine COVIVAC.
The candidate vaccine is being developed by the MoH’s Institute of Vaccines and Medical Biologicals (IVAC).
Speaking at the handover ceremony, Minister of Health Nguyen Thanh Long spoke highly of the support of enterprises, organisations and individuals for Vietnam’s fight against the COVID-19 pandemic.
The first “Made-in-Vietnam” ventilators were produced under the collaboration of the ministry and Vingroup, he noted, adding that the machines have been provided to localities nationwide.
Vietnamese scientists have regarded vaccine development as the key factor to contain the pandemic, and the MoH has spared no efforts in the research for vaccine in order to be able to produce the vaccine as soon as possible.
Minister of Health Nguyen Thanh Long (L) speaks at the event (Photo: VNA)
The COVIVAC vaccine project has been rolled out since May 2020.
Results of pre-clinical trials affirmed its safety and efficiency, and the IVAC has been able to produce three batches of vaccine consisting between 50,000 and 10,000 doses each.
Clinical trials of the vaccines are projected to start this March and complete by October, said IVAC Director Dr Duong Huu Thai.
A dose may cost no higher than 60,000 VND and the vaccine is effective against emerging coronavirus SARS-CoV-2 variants originated from the UK and South Africa, he affirmed.
Meanwhile, the third domestic candidate vaccine VABIOTECH developed by the Company for Vaccine and Biological Production No 1, is also set to enter clinical trials in the coming time./.
The first 35 volunteers received injections of the home-grown Nano Covax in the second phase of human trial at the Military Medical University on February 26.
Nearly 300 volunteers in the Mekong Delta province of Long An are set to receive injections of Nano Covax in the second-stage human clinical trials of the COVID-19 vaccine candidate from Vietnam.
The first 35 volunteers received injections of the locally-produced Nano Covax vaccine in the 2nd phase of human trials at the Military Medical University in Hanoi on February 26. Nanocovax is Vietnam’s first COVID-19 vaccine to reach the human trial stage.
Despite storm-related disruptions and flight delays, the organs were successfully transported via a combination of air and ground travel. All patients are currently stable and recovering well.
The patient, Tieu Viet But, born in 1970 and residing in Binh Tri commune, Binh Son district, the central province of Quang Ngai, was working aboard fishing vessel Qng – 95657TS when the incident occurred at 7:00 am.
All drugs entering hospitals must have a clear origin, so counterfeit drugs are only in the market, not in hospital, affirmed Minister of Health Dao Hong Lan.
To achieve its goal of becoming a developed nation by 2045, Vietnam is prioritising the integration of AI and digital tools into the training of future doctors, said Assoc. Prof. Dr. Nguyen Viet Nhung, Dean of Medicine at University of Medicine and Pharmacy, Vietnam National University (VNU) Hanoi.
Health experts called for collective disease prevention and integrated solutions to achieve zero dengue deaths in the country at an online talk show on June 14.
The PM called for closer, broader, and more effective cooperation with Vietnamese partners, guided by the principles of mutual benefit, joint efforts, shared outcomes, and common development, including promoting stronger public-private partnerships and collaboration with businesses.
Renowned for its expertise in complex surgeries, the hospital has attracted foreign patients seeking treatment for conditions such as kidney and urinary tract stones, urological and gastrointestinal cancers, and male reproductive disorders. Most procedures are performed using advanced techniques, including laparoscopy and robotic surgery. T
Leading Vietnamese companies specialising in respiratory and dermatological treatments, traditional medicine, immune support supplements, and functional foods will have an opportunity to connect with international distributors and secure export deals.
The project aimed to enable early detection and reduce the risk of dangerous complications, targeting patients with chronic diabetes, cardiovascular conditions and metabolic disorders.
A 2023 report by the Vietnam Health Economics Association estimated that the total cost of tobacco-related healthcare and economic losses reached 108 trillion VND (4.14 billion USD) annually – equivalent to 1.14% of GDP and five times higher than the budget revenue generated by the tobacco industry.
All eligible patients will receive surgical interventions and post-operative care in accordance with Vietnamese medical standards and global care protocols.
Medical screenings and surgical interventions for children with disabilities are being carried out at health centers across Dien Bien. So far this year, 242 children have been identified for diagnosis, treatment, surgery, and the provision of assistive devices.
The Red Journey has become the country’s largest and most effective blood donation campaign, leaving a strong impression on the national voluntary blood donation movement.
This case marks the ninth fetal cardiac intervention conducted in HCM City, and it was considered the most technically demanding to date due to the fetus’s extremely early gestational age and the severity of the condition as diagnosed with aortic atresia.
The groundbreaking ceremony took place one day after the VNVC Vaccine JS Company and Sanofi Group exchanged cooperation documents on vaccine production technology transfer under the witness of State President Luong Cuong and French President Emmanuel Macron.
Vietnam’s traditional medicine took centre stage at the International Congress Biopharm Nonclinical Development, BioNCiD 2025, held on May 25-26 in the Cuban city of Varadero, amid growing global interest in sustainable healthcare solutions.
Under the agreement, VNVC and Sanofi will gradually implement technology transfers to enable domestic production of several key Sanofi vaccines that are widely used in Vietnam. In addition, Sanofi will support VNVC in training human resources and quality management in vaccine research and manufacturing.
Despite the ongoing global circulation and unpredictable developments of SARS-CoV-2, the World Health Organisation (WHO) hasn’t issued new warnings about COVID-19, said the Ministry of Health.
At the handover ceremony (Photo: VNA) 
Minister of Health Nguyen Thanh Long (L) speaks at the event (Photo: VNA) 
